The Effect of Infra-Slow Fluctuation Neurofeedback Training on a Cohort of Insomnia Participants
Neurofeedback has gained great interest as a noninvasive treatment for various disorders. However, there is still a lack in literature regarding the effects of infra-slow fluctuation (ISF) neurofeedback training. ISF neurofeedback training is aimed at the lowest brainwave oscillations and attempts to balance dysregulated brainwave activity by inducing shifts in the parasympathetic and sympathetic response. The aim of this study was to determine whether ISF neurofeedback training has a significant effect in participants with insomnia by using quantitative electroencephalography (qEEG), Central Nervous System Vital Signs (CNS VS), and by measuring the changes of physiological vitals. The intervention consisted of 10 sessions for 40 participants separated equally into two groups. Significant results were achieved with improved core temperature (p = .002), finger temperature (p < .001), lower heart rate (p = .002), systolic (p = .003) and diastolic blood pressure (p = .001). The qEEG components significantly improved within standard ranges. An improved neurocognitive state was achieved in terms of CNS VS, with a decrease in depression (p = .003), anxiety (p < .001), and stress (p < .001). This study demonstrated that ISF neurofeedback training should be considered as a viable alternative that can be used concurrently with other insomnia treatment methods.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596
Asher, T., & Wierbowski, B. (2017). Brain training: The future of psychiatric treatment? Harvard University. https://sitn.hms.harvard.edu/flash/2017/brain-training-future-psychiatric-treatment/
Atlantis I 4x4 series system [Apparatus]. (2020). Bedford, OH: BrainMaster Technologies, Inc. https://brainmaster.com/product/atlantis/
Balt, K., Du Toit, P., Smith, M. L., & van Rensburg, C. J. (2020). The effect of infraslow frequency neurofeedback on autonomic nervous system function in adults with anxiety and related diseases. NeuroRegulation, 7(2), 64–74. https://doi.org/10.15540/nr.7.2.64
Ban, H-J., Kim, S. C., Seo, J., Kang, H-B., & Choi, J. K. (2011). Genetic and metabolic characterization of insomnia. PLoS ONE, 6(4), e18455. https://doi.org/10.1371/journal.pone.0018455
BrainAvatar 4.0 Discovery Acquisition (Version 4.6.4) [Computer software]. (2019). Bedford, OH: BrainMaster Technologies Inc. https://www.brainmaster.com/product/brainavatar-4-0-discovery-acquisition/
BrainMaster Discovery 24 Series [Computer software and hardware]. (2019). Bedford, OH: BrainMaster Technologies, Inc.
Carley, D. W., & Farabi, S. S. (2016). Physiology of sleep. Diabetes Spectrum, 29(1), 5–9. https://doi.org/10.2337/diaspect.29.1.5
CNS Vital Signs. (2019). CNS Vital Signs Interpretation Guide. Morrisville, NC: CNS Vital Signs, LLC. https://www.cnsvs.com/WhitePapers/CNS_VS_BriefInterpretation_Guide.pdf
Collura, T. F., & Frederick, J. A. (2016). Handbook of clinical QEEG and neurotherapy. New York, NY: Routledge/Taylor & Francis Group.
Demos, J. N. (2005). Getting started with neurofeedback. W. W. Norton & Company.
Devi, C. B. P., Samreen, S., Kumari, N. K., & Sharma, J. (2018). A review on insomnia: The sleep disorder. The Pharma Innovation Journal, 7(12), 227–230. https://www.thepharmajournal.com/archives/2018/vol7issue12/PartE/7-11-125-807.pdf
Enriquez-Geppert, S., Huster, R. J., & Hermann, C. S. (2017). EEG-neurofeedback as a tool to modulate cognition and behavior: A review tutorial. Frontiers in Human Neuroscience, 11, 51. https://doi.org/10.3389/fnhum.2017.00051
Gajraj, N. M. (2007). Pregabalin: Its pharmacology and use in pain management. Anesthesia & Analgesia, 105(6), 1805–1815. https://doi.org/10.1213/01.ane.0000287643.13410.5e
Judd, B. G., & Sateia, M. J. (2019). Classification of sleep disorders. https://www.uptodate.com/contents/classification-of-sleep-disorders#H4
Kan, D. P. X., Croarkin, P. E., Phang, C. K., & Lee, P. F. (2017). EEG differences between eyes-closed and eyes-open conditions at the resting stage for euthymic participants. Neurophysiology, 49(6), 432–440. https://doi.org/10.1007/s11062-018-9706-6
Krystal, A. D. (2009). A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: The empirical basis for U.S. clinical practice. Sleep Medicine Reviews, 13(4), 265–274. https://doi.org/10.1016/j.smrv.2008.08.001
Krystal, A. D., Prather, A. A., & Ashbrook, L. H. (2019). The assessment and management of insomnia: An update. World Psychiatry, 18(3), 337–352. https://doi.org/10.1002/wps.20674
Krystal, A. D., Richelson, E., & Roth, T. (2013). Review of the histamine system and the clinical effects of H1 antagonists: Basis for a new model for understanding the effects of insomnia medications. Sleep Medicine Reviews, 17(4), 263–272. https://doi.org/10.1016/j.smrv.2012.08.001
Large screen arm blood pressure monitor [Apparatus]. (2020). Capetown, South Africa: Clicks. https://clicks.co.za/clicks_large-screen-arm-bloodpressuremonitor/p/300191? gclid=CjwKCAiA2O39BRBjEiwApB2Ikq98ieHRx5YYmuehv4U lvaaD3GA9J-ZZ35VbjHMPxDeXg5CWSPI8NBoCgc8QAvD_ BwE&gclsrc=aw.ds
Leong, S. L., Vanneste, S., Lim, J., Smith, M., Manning, P., & De Ridder, D. (2018). A randomised, double-blind, placebo-controlled parallel trial of closed-loop infraslow brain training in food addiction. Scientific Reports, 8, 11659. https://doi.org/10.1038/s41598-018-30181-7
Marzbani, H., Marateb, H. R., & Mansourian, M. (2016). Neurofeedback: A comprehensive review on system design, methodology and clinical applications. Basic and Clinical Neuroscience, 7(2), 143–158. https://doi.org/10.15412/J.BCN.03070208
Mayer, G., Wang-Weigand, S., Roth-Schechter, B., Lehmann, R., Staner, C., & Partinen, M. (2009). Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia. Sleep, 32(3), 351–360. https://doi.org/10.1093/sleep/32.3.351
Michelson, D., Snyder, E., Paradis, E., Chengan-Liu, M., Snavely, D. B., Hutzelmann, J., Walsh, J. K., Krystal, A. D., Benca, R. M., Cohn, M., Lines, C., Roth, T., & Herring, W. J. (2014). Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: A phase 3 randomised, double-blind, placebo-controlled trial. The Lancet Neurology, 13(5), 461–471. https://doi.org/10.1016/S1474-4422(14)70053-5
Morin, C. M., Koetter, U., Bastein, C., Ware, J. C., & Wooten, V. (2005). Valerian-hops combination and diphenhydramine for treating insomnia: A randomized placebo-controlled clinical trial. Sleep, 28(11), 1465–1471. https://doi.org/10.1093/sleep/28.11.1465
Ng, K. Y., Leong, M. K, Liang, H., & Paxinos, G. (2017). Melatonin receptors: Distribution in mammalian brain and their respective putative functions. Brain Structure and Function, 222(7), 2921–2939. https://doi.org/10.1007/s00429-017-1439-6
Palva, J. M., & Palva, S. (2012). Infra-slow fluctuations in electrophysiological recordings, blood-oxygenation-level-dependent signals, and psychophysical time series. NeuroImage, 62(4), 2201–2211. https://doi.org/10.1016/j.neuroimage.2012.02.060
Peché, D. (2015). ISF or Infra Slow Fluctuation Training. Neurofeedback Therapy. http://www.neurofeedback-therapy.co.za/Wordpress/2015/02/26/isf-or-infra-slow-frequency-training/
Perlis, M. L., Smith, M. T., Andrews, P. J., Orff, H., & Giles, D. E. (2001). Beta/gamma EEG activity in patients with primary and secondary insomnia and good sleeper controls. Sleep, 24(1), 110–117. https://doi.org/10.1093/sleep/24.1.110
Pigott, H. E., & Cannon, R. (2014). Neurofeedback is the best available first-line treatment for ADHD: What is the evidence for this claim? NeuroRegulation, 1(1), 4–23. https://doi.org/10.15540/nr.1.1.4
qEEG-Pro [Database]. (2019). Netherlands: qEEG-Pro B. V. https://qeegpro.eegprofessionals.nl/database/
Riemann, D., Spiegelhalder, K., Feige, B., Voderholzer, U., Berger, M., Perlis, M., & Nissen, C. (2010). The hyperarousal model of insomnia: A review of the concept and its evidence. Sleep Medicine Reviews, 14(1), 19–31. https://doi.org/10.1016/j.smrv.2009.04.002
Rose, M. A., & Kam, P. C. A. (2002). Gabapentin: Pharmacology and its use in pain management. Anaesthesia, 57(5), 451–462. https://doi.org/10.1046/j.0003-2409.2001.02399.x
Sieghart, W., & Sperk, G. (2002). Subunit composition, distribution and function of GABA(a) receptor subtypes. Current Topics in Medicinal Chemistry, 2(8), 795–816. https://doi.org/10.2174/1568026023393507
Sintered Silver/Silver Chloride Electrodes. (2019). https://www.eeginfoeurope.com/fileadmin/images/produkte/elektroden/sintered-electrodes.pdf
Smith, M. L. (2013). Infra-slow fluctuation training; On the down-low in neuromodulation. NeuroConnections, Fall 2013, 38–46.
Smith, M. (2018a). The benefits of infraslow neurofeedback training. Neurofeedback Services of New York. https://neurofeedbackservicesny.com/the-benefits-of-infraslow-neurofeedback-training/
Smith, M. (2018b). Types of neurofeedback. Neurofeedback Services of New York. https://neurofeedbackservicesny.com/types-of-neurofeedback/
Smith, M. L., Collura, T. F., Ferrera, J., de Vries, J. (2014). Infra-slow fluctuation training in clinical practice: A technical history. NeuroRegulation, 1(2), 187–207. https://doi.org/10.15540.nr.1.2.187
Stress Thermometer SC911 [Apparatus]. (2020). Clinton Township, MI: Bio-Medical Instruments, Inc. https://bio-medical.com/stress-thermometer-sc911.html
Warner, S. (2013). Cheat Sheet for Neurofeedback. Stress Therapy Solutions. http://www.stresstherapysolutions.com/uploads//STSCheatSheetoftheBrain.pdf
Wing, Y. K., Zhang, J., Lam, S. P., Li, S. X., Tang, N. L., Lai, K. Y., & Li, A. M. (2012). Familial aggregation and heritability of insomnia in a community-based study. Sleep Medicine, 13(8), 985–990. https://doi.org/10.1016/j.sleep.2012.04.013
Zhang, J., Lam, S.-P., Li, S. X., Ma, R. C. W., Kong, A. P. S., Chan, M. H. M., Ho, C-S., Li, A. M., & Wing, Y.-K. (2014). A community-based study on the association between insomnia and hypothalamic-pituitary-adrenal axis: Sex and pubertal influences. The Journal of Clinical Endocrinology & Metabolism, 99(6), 2277–2287. https://doi.org/10.1210/jc.2013-3728
Copyright (c) 2021 Melissa Bekker, Karlien Balt, Priyesh Bipath, Joyce Jordaan, Peet du Toit
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).